ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Operations & Power
Members focus on the dissemination of knowledge and information in the area of power reactors with particular application to the production of electric power and process heat. The division sponsors meetings on the coverage of applied nuclear science and engineering as related to power plants, non-power reactors, and other nuclear facilities. It encourages and assists with the dissemination of knowledge pertinent to the safe and efficient operation of nuclear facilities through professional staff development, information exchange, and supporting the generation of viable solutions to current issues.
Meeting Spotlight
2024 ANS Annual Conference
June 16–19, 2024
Las Vegas, NV|Mandalay Bay Resort and Casino
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Apr 2024
Jan 2024
Latest Journal Issues
Nuclear Science and Engineering
May 2024
Nuclear Technology
Fusion Science and Technology
Latest News
DOE issues RFQ for clean-energy projects at WIPP
The Department of Energy has issued a request for qualifications (RFQ) for interested parties that are looking to establish carbon pollution–free electricity (CFE) projects at its Waste Isolation Pilot Plant site in New Mexico.
Technical Session|Panel|Sponsored by IRD
Monday, November 16, 2020|1:00–3:10PM EST
Session Chairs:
Lin-Wen Hu (MIT)
James Bowen (PNNL)
Session Organizer:
Staff Producer:
Rick Michal (American Nuclear Society)
Radioisotopes produced from nuclear reactors and accelerators are widely used for medical diagnostics and cancer therapy. For example, Tc-99m (decay product of Mo-99) is used in more than 80% of nuclear medicine diagnostic procedures. I-131 is widely used to treat thyroid cancer and applications of Lu-177 have increased in recent years for targeted therapy. This panel session will feature the following speakers to discuss the advancement and status of domestic production and applications of medical isotopes: 1) Peter J. Karcz: NNSA’s Mo-99 Program: Accelerating Reliable, Non-HEU Mo-99 Production Capabilities in the U.S., 2) Greg Piefer: Progress at SHINE Medical in Commercializing Mo-99 and Lu-177 for Diagnostic and Therapeutic Applications, 3) Ira Goldman: Achieving Security of Supply of Medical Radioisotopes, 4) Les Foyto: MURR’s Role in Supplying Isotopes for Research and Patient Care, and 5) Jon Neuhoff: DOE Production of Radioisotopes for Medical Research, Diagnosis, and Treatment
To access the session recording, you must be logged in and registered for the meeting.
Register NowLog In
To access session resources, you must be logged in and registered for the meeting.
To join the conversation, you must be logged in and registered for the meeting.